ZUG, Switzerland, NOV 21, 2024 — SHL Medical, a world leader in self-injection solutions, today announced plans to establish SHL Advantec – a dynamic sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries. The establishment of SHL Advantec is part of SHL Medical’s ambitious expansion strategy and ongoing commitment…
SHL Medical participates in the NSTC Science Train Program for the third consecutive year.
The latest article in World Pharmaceutical Frontiers takes a closer look on SHL’s SMART system.
In the October issue of ONdrug Delivery magazine, SHL Medical’s Vince Masciopinto introduces Elexy™, our reusable electromechanical autoinjector designed to support combination product development at every stage—preclinical, clinical, and commercial.
SHL Medical, a world-leading solutions provider of advanced drug delivery systems such as autoinjectors, pen injectors, and innovative specialty delivery systems has announced a strategic partnership with Grand River Aseptic Manufacturing (GRAM), a highly regarded contract development and manufacturing organization (CDMO) specializing in sterile injectable biologics and scalable pharmaceutical manufacturing solutions tailored to diverse client needs.
SHL Medical announces our debut at Fakuma 2024 in Friedrichshafen, Germany.
Kymanox Corporation (“Kymanox”), a professional services company exclusively serving life sciences, and SHL Medical AG (“SHL”), a world-leading solutions provider of advanced drug delivery systems, announced today that they have signed a non-exclusive strategic partnership agreement.
SHL Medical signed a Letter of Intent with Taiwan MOEA for the fourth time.
SHL Medical debuts its first reusable electromechanical autoinjector.
Update your browser to view this website correctly. Update my browser now
